Filing Flows › Humana (HUM) › Guidance & outlook
Humana (HUM) guidance and outlook
Humana (HUM) raised its guidance on Nov 6, 2026: EPS $9.50 for FY2026; EPS $15.09 for FY2026; EPS $2.00 for FY2026; EPS $9.84 for FY2025. Humana's 10-Q filed Nov 6, 2026 makes 7 forward-looking statements, 1 of them new and 1 no longer said since the filing before.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EPS | FY2026 | $9.50 | raised |
| EPS | FY2026 | $15.09 | raised |
| EPS | FY2026 | $2.00 | reaffirmed |
| EPS | FY2025 | $9.84 | reaffirmed |
From the earnings release filed Nov 6, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 6, 2026
- When used in filings with the Securities and Exchange Commission, or SEC, in our press releases, investor presentations, and in oral statements made by or with the approval of one of our executive officers, the words or phrases like “believes,” “expects,” “anticipates,” “intends,” “likely will result,” “estimates,” “projects” or variations of such words and similar expressions are intended to identify such…
- We expect to incur additional charges over the course of the program.
- Our Chief Executive Officer, the Chief Operating Decision Maker, utilizes these segment groupings and results of each segment, measured by income (loss) from operations, to assess performance and allocate resources primarily during our annual budget process and periodic forecast updates.
- Our approach to primary, physician-directed care for our members aims to provide quality care that is consistent, integrated, cost-effective, and member-focused, provided by both employed physicians and physicians with network contract arrangements.
- We are and will continue to be regularly subject to new laws and regulations, changes to existing laws and regulations, and judicial determinations that impact the interpretation and applicability of those laws and regulations.
- new · We expect significant operating cash outflows in the remainder of 2026 as our results from operations and working capital are impacted by seasonal patterns.
- In May 2025, we entered into a Rule 10b5-1 Repurchase Plan to repurchase a portion of our $750 million aggregate principal amount of 1.350% senior notes maturing in February 2027 and a portion of our $600 million aggregate principal amount of 3.950% senior notes maturing in March 2027 during the period beginning on May 1, 2025 and ending on August 29, 2025.
Humana's latest quarter
Humana, Q3 2026: revenue $41.2B (+26% year over year), operating margin 0.2%, net earnings $161M, operating cash flow $2.2B. The chart follows the revenue to costs, profit and cash.
Questions
Did Humana raise or lower its guidance?
Humana (HUM) raised its guidance on Nov 6, 2026: EPS $9.50 for FY2026; EPS $15.09 for FY2026; EPS $2.00 for FY2026; EPS $9.84 for FY2025.
What does Humana expect?
We expect significant operating cash outflows in the remainder of 2026 as our results from operations and working capital are impacted by seasonal patterns.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.